Products - Infection - Sexually transmitted

Sexually transmitted

Contact our Infectious Disease Product Team for further details and information

Information

Sexually transmitted infections (STIs) can be caused by bacteria (e.g. Treponema pallidum, Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma), viruses (e.g. HSV) or parasites (Trichomonas vaginalis), which are transmitted from person to person by vaginal, anal or oral sex. The course, symptoms and consequences of STIs can differ significantly depending on the causative pathogen. In many cases, the infection is asymptomatic, so that it remains undiscovered for a long time and is only diagnosed when it has become chronic.

Diagnostics

Infections with these pathogens often cause inflammation of the urogenital tract, which may ascend and lead to e.g. infertility. In addition to the consequences for the patient, infections with most of the mentioned pathogens can also lead to intrauterine fetal loss, preterm birth or damage to the unborn child. Moreover, many pathogens can be transmitted to the newborn during birth, causing severe postnatal infections.

The commonly used detection methods for STI are direct methods, in which the pathogen is detected by PCR or culture, and indirect methods, i.e. detection of pathogen-specific antibodies. Since detection by culturing is especially time-consuming and difficult for Chlamydia, Mycoplasma, Ureaplasma and Treponema, other detection methods, e.g. PCR-based and/or serological procedures, are generally recommended or required for these pathogens.

Sexually transmitted products

For Research Use Only. Not For Use In Diagnostic Procedures.
The individual product regulatory statements may vary, please refer to the instructions for use for more information.

wdt_ID Method Parameter Substrate Species/ Antigen
682 IFA antibodies against Treponema pallidum
unspecific FTA IgG positive control
683 IFA antibodies against Treponema pallidum
unspecific FTA IgM positive control
684 IFA Treponema pallidum
(FTA-ABS)
bacterial
smear
verification BIOCHIP
(2 BIOCHIPs per field)
685 IFA Treponema pallidum
FTA negative control
686 ELISA Treponema pallidum antigen-coated
microplate wells
recombinant antigens
15 kDa, 17 kDa, 47 kDa,
42 kDa (TmpA)
687 ELISA Treponema pallidum
incl. IgG/RF absorbent
antigen-coated
microplate wells
recombinant antigens
15 kDa, 17 kDa, 47 kDa,
42 kDa (TmpA)
688 ELISA Treponema pallidum
Screen ELISA
antigen-coated
microplate wells
recombinant antigens
15 kDa, 17 kDa, 47 kDa,
42 kDa (TmpA)
689 EUROLINE positive control serum: IgG, human, 50x concentrated
for Treponema pallidum
690 EUROLINE positive control serum: IgM, human, 50x concentrated
for Treponema pallidum
691 EUROLINE Treponema pallidum
(TpN15, TpN17, TmpA, TpN47 separately)
692 WESTERNBLOT antibodies against Treponema pallidum
IgG positive control
693 WESTERNBLOT antibodies against Treponema pallidum
IgM positive control
694 WESTERNBLOT Treponema pallidum Westernblot 15 kDa, 17 kDa,
45 kDa (tmpA), 47 kDa
695 IFA antibodies against Treponema pallidum
IgG positive control for FTA absorption
696 WESTERNBLOT EUROLINE-WB
Treponema pallidum
plus cardiolipin
Westernblot 15 kDa, 17 kDa, 45 kDa (tmpA), 47 kDa
plus purified cardiolipin
697 ELISA CSQ pair of controls
anti-Treponema pallidum (IgG)
698 ELISA Treponema pallidum
antibody determination in CSF
antigen-coated
microplate wells
recombinant antigens
15 kDa, 17 kDa, 47 kDa,
42 kDa (TmpA)
699 IFA Treponema pallidum
(FTA-ABS)
bacterial
smears
verification BIOCHIP
(3 BIOCHIPs per field)
T. pallidum
T. phagedenis
700 IFA antibodies against Chlamydia trachomatis
IgA positive control
701 IFA antibodies against Chlamydia trachomatis
IgG positive control
702 IFA antibodies against Chlamydia trachomatis
IgM positive control
703 IFA Chlamydia
trachomatis
infected cells EU 40
704 ELISA Chlamydia trachomatis antigen-coated
microplate wells
native MOMP antigen
from C. trachomatis
705 ELISA Chlamydia trachomatis antigen-coated
microplate wells
native MOMP antigen
from C. trachomatis
706 ELISA Chlamydia trachomatis
incl. IgG/RF absorbent
antigen-coated
microplate wells
native MOMP antigen
from C. trachomatis
Method Parameter Substrate Species/ Antigen
Contact our Infectious Disease Product Team for further details and information
Download Our Latest <br/>EUROIMMUN US Product Catalog

Product Catalog

Download Our Latest
EUROIMMUN US Product Catalog

Download The EUROIMMUN US Product Catalog (PDF)

2024 EUROIMMUN US

Privacy Policy | Website Terms and Conditions | Cookie Notice and Settings | Consent Preferences | Sitemap